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Abstract Infantile cortical hyperostosis (ICH, OMIM
114000) is a rare familial disorder which affects infants.
It spontaneously heals in the first years of life. The disease
is characterized by regressive subperiosteal hyperosteo-
genesis mainly affecting long bones, mandible, clavicles,
and ribs which are remarkably swollen and deformed on
X-rays. But it is also important to take into consideration
the autosomal dominant pattern of inheritance to detect it.
In 2005 Gensure et al. detected 3040C→T mutation in
COL1A1 gene in three unrelated ICH families. Four
generations of patients belonging to the same family were
examined in our study. Molecular testing has now
disclosed a pathogenic mutation in nine of them. The
patients spontaneously recovered. Although our paper
shows a distinct correlation between R836C mutation
and ICH, there is a certain interindividual and intra-
familial variability.
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Introduction
Infantile cortical hyperostosis (ICH, OMIM 114000) was
first reported by Roske [26] and subsequently studied by
De Toni who recognized the congenital and regressive
aspects of this disorder [13, 14]. Caffey and Silverman [9]
and Caffey [8] formally defined ICH, which is a neonatal
and infantile familial disease, spontaneously healing in the
first years of life. The disease is characterized by regressive
subperiosteal hyperosteogenesis mainly affecting the long
bones, mandible, clavicles, and ribs, which are remarkably
swollen and deformed on X-ray. The presence of fever,
inflammatory signs, and pain led clinicians to suspect
different disorders, in particular those caused by infectious
agents [2, 22, 25, 30]. Familial clustering has been reported
by several authors who also outlined the autosomal
dominant pattern of inheritance and a possible reduced
penetrance [1, 4, 6, 10, 15, 17, 19, 20, 23, 24, 27, 31].
A genome-wide analysis in three unrelated ICH families
allowed Gensure et al. [18] to map the disease locus on
chromosome 17q21. All affected individuals were found to
be heterozygous for a missense mutation (3040C→T) in the
COL1A1 that altered residue 836 (R836C). Suphapeetiporn
et al. [29] and Cho et al. [11] corroborated these results by
confirming the same mutation in a Thai ICH family and a
Korean one.
In the present paper, we report the molecular analysis of
the COL1A1 gene in four generations of an ICH Italian
family.
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Patients
The affected individuals belong to an Italian Piëmontees
family in which ICH has occurred for at least four generations
(Figs. 1 and 2). Three of the nine investigated patients were
diagnosed in 1969 [15] and one in 1979 [10]. They were
reevaluated during this study together with five new patients
(IV-11, VI-11, V-3, VII-2, and VII-3). The relevant features
of the nine patients are summarized in Table 1.
In these nine patients and in five asymptomatic family
members (VII-1, VI-5, VI-7, VI-9, and VI-10), mutation
analysis of COL1A1 was performed. Molecular testing was
also performed in a subject (V-1) who was distantly related
to her affected husband.
Informed consent was obtained for all patients. Publication
of the material included in this work has been authorized in
accordance with the terms of the Italian privacy law 196/03.
Methods
DNA extraction and quantification
gDNA was isolated from 300 μl of a peripheral whole-
blood sample using PureGene DNA isolation kit accord-
ing to the manufacturer's instructions (Gentra Systems,
Minneapolis, USA). Accurate quantification of obtained
gDNA was made by fluorimetric method (Qubit fluorom-
eter; Invitrogen; Carlsbad, USA).
PCR amplification
Amplification of exon 41 of COL1A1 gene was carried out,
using specific intronic primers in a 25-μl final volume with
50 ng of gDNA, 250 nM of each primer, 200 μM of each
dNTP, 1.5 mM MgCl2,R x nB u f f e r ,a n d1 . 2 5Uo f
Platinum® Taq DNA Polymerase.
A commercial kit (Invitrogen, Carlsbad, USA) was used
for Taq, buffer, MgCl2, and dNTPs.
PCR product purification and sequence analysis
The amplified fragment was purified by a selective DNA/
silica membrane binding reaction carried out on a column
support (Illustra GFX PCR DNA and gel band purification
kit; GE Healthcare, Buckinghamshire, UK), and 50 fmol of
the same PCR product was used for the dye terminator
cycle sequencing reaction with the CEQ DTCS Quick Start
Kit (Beckman Coulter, Fullerton, USA) according to the
manufacturer's protocol. The sequencing reaction product
was purified and analyzed with a capillary electrophoresis
sequencer (CEQ 8800; Beckman Coulter, Fullerton, USA).
Two different PCR reactions were made and sequenced for
each patient to exclude that heterozygotes were due to rare
spontaneous polymerization errors of Taq activity.
Results
Mutation analysis of COL1A1 gene (Fig. 3) was performed
in 15 subjects. Nine of them (VI-1, VII-2, V-2, VI-4, VII-3,
V-5, IV-11, V-3, and VI-11) were found to have a
heterozygous Arg836Cys mutation. The onset of the
disease began between the first 10 and 60 days of life.
Six patients showed evident clinical features of ICH. In
particular the following bones were affected: tibial swelling
occurred in six patients, ulnar and radial in four, femoral in
three, fibular in three, mandibular in two, humeral in two,
and clavicular in one (Table 1). For subjects IV-11 and V-3,
aged 83 and 71 years respectively, there were no records of
any ICH symptoms in the neonatal and infant age although
the former is an obligate carrier.
Patient VI-11 is a heterozygous asymptomatic individu-
al. Subjects VII-1, VI-5, VI-7, VI-9, VI-10, and V-1 had a
wild-type COL1A1 genotype.
Fig. 1 Pedigree of the Italian
ICH family. Symbols: arrow,
proband; black, affected indi-
viduals with COL1A1 mutation;
black-gray, heterozygous indi-
vidual which did not remember
ICH data; gray with central
black dot, heterozygous asymp-
tomatic; gray, ICH suspected;
individuals tested negative are
indicated with an horizontal line
over their symbol; white, unaf-
fected individuals
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The detection of the COL1A1 gene mutation in individuals
affected by ICH [18] has shown the molecular make up of
this disorder inherited as an autosomal dominant trait,
which manifests itself in the first months and years of life
and results in early spontaneous recovery. In this study we
carried out mutational analysis in 15 subjects of the same
family and found heterozygous missense mutation in exon
41 (3040C→T, R836C) in 9 of them.
Fig. 2 a Patient VI-1 at 14 days old, mandibular deformation. b X-ray
of arms. c At 1 year old, bowed arms. d At 3 years old, swelling
regression. e At 7 years old, bowed right forearm. f Patient V-5 at
2 months old, swelling of leg. g At 3 years old, full recovery. h Patient
VII-2 at 2 months old, X-ray of leg. i, j At 2 years old, light swelling
of mandible and leg
Eur J Pediatr (2011) 170:1385–1390 1387There have been disagreements on the management of
ICH individuals, and the use of corticosteroid therapy has
been proposed [7, 12, 16]. However, this therapy was not
beneficial in our first patient (VI-1) and after 1 month it
was stopped. All the other ICH individuals in the same
family were not treated and reached a spontaneous full
recovery.
Our study confirms that individuals heterozygous for
R836C mutation have a distinct clinical disorder in
agreement with the findings of Gensure et al. [18] and
Suphapeetiporn et al. [29]. Allelic COL1A1 mutations have
been reported in association with Ehlers–Danlos syndrome
and osteogenesis imperfecta. None of the known individ-
uals with R836C mutation had clinical or radiographic
features consistent with these two diseases (joint hyper-
laxity, hyperexstensibility skin, gray-blue sclerae, dentino-
genesis imperfecta, premature hearing loss, short stature,
deformities, and scoliosis).
Table 1 Clinical and radiological features of nine patients with R836C COL1A1 mutation
Clinical features VI-2 VII-2 V-2 VI-4 VII-3 V-5 IV-11 VI-11 V-3
S e x F MM F MMMMM
Weight at birth (g) 2,750 3,300 / 2,950 3,200 3,750 / 4,300 /
Onset of ICH (days) 14 60 15 60 10 20 / − /
Swelling
Tibia + + + + + + / − /
Ulna + + − +++/ − /
Radius + + − +++/ − /
Femur + −− −−+/ − /
Mandible + + −− − − / − /
Fibula − ++ ++− / − /
Humerus −−− + − +/ − /
Clavicle −−− −−+/ − /
Walking unsupported (months) 20 16 20 13 17 20 / 12 /
Clinical improvement, age (months) 36 24 / 12 12 4 / − /
Clinical recovery (years) 7 / 12 5 2 3 / − /
Age at reevaluation (years) 42 2 68 31 5 55 83 22 71
Height (cm) 156 85 168 166 114 182 175 190 165
F female, M male, + presence of clinical sign, − absence of clinical sign, / no data available
Fig. 3 a Representation of
COL1A1 gene; the 41 exons
are shown as filled boxes and the
mutation Arg836Cys related to
ICH was also indicated. b Ge-
nomic DNA wild type around
the site of mutation. c Sequence
of a ICH patient with a hetero-
zygous single-nucleotide substi-
tution converting an arginine to
cysteine (reference sequence
NP_000079.2)
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tence of ICH features in adulthood. A few individuals
investigated in the first studies of this disorder were
described as having persisting deformities throughout
adolescence and adulthood [3, 5, 9]. More recently,
Suphapeetiporn et al. [29] have reported two ICH
individuals aged 50 and 75 years, with proved COL1A1
mutation, showing persisting deformities of the long
bones. The adult mutated individuals studied by Gensure
et al. [18] had no skeletal deformation while this was
reported for the Thai mutated patients [29]. All our
mutated adult individuals reached the target height
(Table 1) and at present, they show no persisting ICH
symptoms. In four of them, recovery took place between
the third and the twelfth years of age. No new X-ray
analysis was considered necessary.
Barba and Freriks [1] radiographically reported lesions
in the long bones during the last month of gestation in two
fetuses that exhibited ICH postnatally and suggested a
possible autosomal recessive pattern of inheritance. Other
studies have argued that the prenatal onset of ICH should
be regarded as a distinct disorder [27]. Schweiger et al. [28]
reported 43 cases with prenatal onset of ICH and showed
that those born before 35 weeks of gestation had a poor
prognosis (possible autosomal recessive inheritance) com-
pared to those born after 35 weeks, who were shown to
have an autosomal dominant mutation. It has been
suggested that early onset of fetus ICH is usually lethal
because of massive hepatic myeloid hyperplasia resulting in
enlarged liver, ascites, anasarca, and pulmonary hypoplasia
[32]. However, mutational analysis of COL1A1 gene in two
fetuses manifesting ICH characteristics disclosed a wild
genotype [18]. Kamoun-Goldrat et al. [21] reported an ICH
fetus terminated at 30 weeks after a diagnosis of severe
osteogenesis imperfecta. A postmortem test confirmed ICH.
No patient in our family developed any prenatal ICH
symptom.
In conclusion, the mutational origins of this disease are
important in making a correct diagnosis and ensuring ICH
patients are given the right treatment. Available data point
to a wide clinical variability among individuals with R836C
mutation. Different outcomes have been observed in a
minority of these patients in agreement with the interindi-
vidual and intra-familial variability to be expected for an
autosomal dominant disorder.
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